It appears that research funding of $80 million will again be directed for use to study prostate cancer through the Department of Defense’s Congressionally Directed Medical Research Program (DoD CDMRP) for the financial year 2012. This is a big and important “win” for prostate cancer research during a time of fiscal constraint.
Filed under: Uncategorized | Tagged: CDMRP, research | 3 Comments »

Search for new and
ongoing trials on the
CTAG PCa web site
